
XtalPi
North America, Massachusetts, United States, Cambridge
Description
XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.
Investor Profile
XtalPi has backed more than 15 startups, with 9 new investments in the last 12 months alone. The firm has led 6 rounds, about 40% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in China, United States, Switzerland.
- Strong thematic focus on Biotechnology, Pharmaceutical, Medical.
- Led 6 rounds in the past year.
Stage Focus
- Seed (40%)
- Series A (27%)
- Series Unknown (13%)
- Series B (7%)
- Angel (7%)
- Corporate Round (7%)
Country Focus
- China (47%)
- United States (20%)
- Switzerland (13%)
- United Kingdom (7%)
- Japan (7%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Medical
- Biopharma
- Health Care
- Artificial Intelligence (Ai)
- Therapeutics
- Medical Device
- Alternative Medicine
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does XtalPi frequently co-invest with?
Which angels does XtalPi often collaborate with?
What are some of recent deals done by XtalPi?
Find More Investors Like XtalPi
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









